SOLUTIONS FOR PHARMA
In silico trials enable scientists to unleash the power of Modeling & Simulation in any stage of drug preclinical and clinical development, to characterize as early as possible the best candidates while assessing their efficacy and safety.
Identify and disqualify bad candidates early in the process to avoid investing on them. Learn which molecules and doses can be safe before any in vivo test.
Use virtual patients to enhance your trials and make them succesfull even when recruitment is difficult to enroll and also to take into consideration a wider variety of cases, different ages, pathologies or special populations.
InSilicoDISCOVERY
Solution for Pharma
Our chemotoxicity tool predicts potential toxicological endpoints of a compound.
InSilicoDISCOVERY
Solution for Pharma
Explore and estimates the interactions and the affinity of a ligand towards a biological target.
InSilicoNEURO
Solution for Pharma
Our Amyotrophic Lateral Sclerosis tool can be used for clinical trial design, synthetic arms for clinical trials, or personalized prognosis prediction.
InSilicoDIABETES
Solution for Pharma
Predicts the effect of anti-diabetic drugs and therapies in a virtual population.
InSilicoIMMUNO
Solution for Pharma
Early immunogenecity risk screen emulates the CD4+ T-cells proliferation assay to determine the potential immunogenicity risk of new protein sequences.